These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8546857)

  • 1. Neuropsychological features of progressive supranuclear palsy.
    Grafman J; Litvan I; Stark M
    Brain Cogn; 1995 Aug; 28(3):311-20. PubMed ID: 8546857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy.
    Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW
    Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy.
    Millar D; Griffiths P; Zermansky AJ; Burn DJ
    Mov Disord; 2006 Feb; 21(2):199-207. PubMed ID: 16200534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with progressive supranuclear palsy.
    Schrag A; Selai C; Davis J; Lees AJ; Jahanshahi M; Quinn N
    Mov Disord; 2003 Dec; 18(12):1464-9. PubMed ID: 14673883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limb apraxia and cognitive impairment in progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurocase; 2005 Aug; 11(4):263-7. PubMed ID: 16093226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
    Cordato NJ; Halliday GM; Caine D; Morris JG
    Mov Disord; 2006 May; 21(5):632-8. PubMed ID: 16353177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy: analysis of six cases.
    Marra M; Toni V; Trianni G; Coppola G
    Neurol Sci; 2003 Oct; 24(3):186-7. PubMed ID: 14598079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive deficits in progressive supranuclear palsy].
    Kułakowska A; Pyd E; Halicka D; Pogorzelski R; Drozdowski W
    Neurol Neurochir Pol; 2003; 37 Suppl 5():203-10. PubMed ID: 15098348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive supranuclear palsy: neurological, neuropathological and neuropsychological aspects].
    Gómez-Haro C; Espert-Tortajada R; Gadea-Doménech M; Navarro-Humanes JF
    Rev Neurol; 1999 Nov 16-30; 29(10):936-56. PubMed ID: 10637844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter correlates of behavioral severity in progressive supranuclear palsy.
    Josephs KA; Whitwell JL; Eggers SD; Senjem ML; Jack CR
    Mov Disord; 2011 Feb; 26(3):493-8. PubMed ID: 21462261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago.
    Magherini A; Litvan I
    Neurocase; 2005 Aug; 11(4):250-62. PubMed ID: 16093225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy.
    O'Keeffe FM; Murray B; Coen RF; Dockree PM; Bellgrove MA; Garavan H; Lynch T; Robertson IH
    Brain; 2007 Mar; 130(Pt 3):753-64. PubMed ID: 17347257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy.
    Zakzanis KK; Leach L; Freedman M
    Brain Cogn; 1998 Dec; 38(3):283-96. PubMed ID: 9841787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.
    Josephs KA; Dickson DW
    Mov Disord; 2003 Sep; 18(9):1018-26. PubMed ID: 14502669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.